Abstract-Polymorphisms are distributed differently in populations, including those of regions, ethnic groups, and diseased patients. In order to investigate variation in nucleotide sequences in normal individuals, we isolated genomic DNA from the blood of healthy Japanese individuals and sequenced the 5' untranslated region (5' UTR) of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) gene and the gene promoter, intron, and exon nucleotides of p53, p14 ARF , murine double minute 2 (MDM2), and the β 2 and β 3 adrenoceptor ( AR). We found polymorphisms in these regions, including a deletion at positions -465 to -463 and a substitution at position -404 in PTEN and a substitution at position -4924 in p14 ARF , in nor mal individuals. Individuals with or without the PTEN polymorphism harbored a different distribution of polymorphisms, including simultaneous alterations in nucleotides of p53, MDM2, and β 3 AR, and also har bored some polymorphic nucleotides located in the same set of associatively altered nucleotides. Our results show that multiple nucleotides, including the PTEN nucleotides, are altered in normal Japanese individuals and provide useful information for genotyping studies in individuals and populations.
INTRODUCTION
Control subjects harbor polymorphisms of the phosphatase and tensin homolog deleted on chromo some 10 (PTEN) gene, including those at positions ⎯1026, -903 [1] , and -9 [2] in the 5' untranslated region (5' UTR). The PTEN -1026 and -903 poly morphisms are located around the binding sites of transcription factors such as Sp1 [1] , and the -9 poly morphism is located close to a Kozak sequence. A polymorphism of the p53 gene in codon 72, which is commonly found in various populations, including the Japanese population [3] , is distributed latitude dependently among resident populations of eastern Asia in areas located from 10-50° north; the distribu tion of this polymorphism is also associated with win ter temperatures [4] . In addition, an intron polymor phism at position SNP309 of the murine double minute 2 (MDM2) gene shows a different distribution among regions that are exposed to distinct levels of ultraviolet radiation [4] . A PTEN promoter polymor phism at position -1142, which is found in normal Japanese individuals, is located within a p53 binding element [5] , and a p53 promoter polymorphism at the -824 to -818 poly(C) positions (a C to C insertion 1 The article is published in the original. polymorphism) found in a normal Japanese popula tion [6] and the PTEN -1142 promoter polymor phism alter cellular transcriptional activity in the pres ence or absence of serum in culture medium [5] . PTEN gene expression is increased at 32°C in cells expressing a temperature sensitive p53 mutant [7] and differs among individuals, including control subjects [1] and those with non diseased tissues [8, 9] .
Polymorphisms are reportedly associated with individual predispositions, including those to diseases. A population based study using polymerase chain reaction single strand conformational polymorphism (PCR SSCP) and direct nucleotide sequencing anal yses has shown that the -9 polymorphism in the PTEN 5' UTR is associated with a disease of diabetes exhibiting metabolic abnormalities in a Japanese pop ulation [2] . A similar association with diabetes has also been reported for other gene polymorphisms, includ ing a p14 ARF polymorphism at position -3735, in a European population [10] . Some promoter polymor phisms within the p14 ARF 4.5 kb promoter, including the ⎯3735 polymorphism, have been observed in an Asian (Korean) population [11] . Further, other asso ciation studies based on populations or follow up observations have shown that exon 1 polymorphisms of the β 2 and β 3 adrenoceptor ( AR) genes at codons POLYMORPHISMS IN THE 5' UTR OF PTEN 75 27 and 64 are associated with not only metabolic dis eases, such as diabetes and obesity [12, 13] , but also other diseases, such as hypertension [14] and cancers of the breast [15] and colon [16] . In such association studies, polymorphisms are observed in control sub jects who do not suffer from disease and are not neces sarily observed in all of the patients. Individuals, including non cancer patients and normal individuals, harbor multiple nucleotide alter ations in each gene; e.g., alterations in intron 1, 3, 4, and 8 of the PTEN gene [17] or in exon 1 at position -628 and intron 1 at positions -466 and -215 (SNP309) of the MDM2 gene [6] . The MDM2 -628 and -466 polymorphisms observed in normal Japa nese individuals are included in associative alterations in nucleotides [6] , and the PTEN intron 1, 3, 4, and 8 polymorphisms observed in individuals, including non cancer patients, are involved in a highly linked sequence of nucleotides [17] . The SNP309 polymor phism of MDM2 is reportedly in linkage disequilib rium with other polymorphisms of MDM2 and is dis tributed differently between ethnic groups [18] . Simi lar linkage has also been shown for the p14 ARF promoter polymorphisms in a Korean population [11] . An association study has reported that the pres ence of the -9 polymorphism of the PTEN 5' UTR decreases the risk of some carcinomas in the absence of another PTEN intronic polymorphism (a sequence insertion of five nucleotides) in a Chinese population [19] . Polymorphic nucleotides linked with other poly morphisms are useful for genotyping studies in popu lations.
In the present study, in order to investigate whether normal individuals harbor other PTEN polymor phisms and whether each individual harbors multiple nucleotide alterations, we isolated genomic DNA from the blood of healthy Japanese individuals and sequenced the 5' UTR of PTEN together with other gene promoter, intron, and exon nucleotides at posi tions -824 to -818 of p53; position -3735 of p14 ARF ; positions -628, -466, and -215 (SNP309) of MDM2; and codons 27 and 64 of β 2 and β 3 AR. We also sequenced the nucleotides upstream of the p14 ARF 4.5 kb promoter sequence and searched polymorphic nucleotides associatively altered with other p14 ARF polymorphisms.
MATERIALS AND METHODS
Study subjects and genomic DNA extraction. Human peripheral blood was obtained from 21 healthy Japanese students (in which male students outnumber female students) in their early twenties who consented to have their DNA sequenced for identification of polymorphisms. Genomic DNA was extracted from whole blood with a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). DNA analysis showed that the frequency of a known polymorphism (NAD(P)H:quinone oxidoreductase (NQO1) poly morphism (C609T); [20] ) was similar to that previ ously found in control Japanese subjects (the fre quency of the NQO1 polymorphism was 48% homozy gous C/C, 38% heterozygous C/T, and 14% homozygous T/T). We investigated the frequency of the examined polymorphism by using samples obtained from 12 randomly selected students (the polymorphic frequency of NQO1 was 58.3% homozygous C/C, 33.3% heterozygous C/T, and 8.3% homozygous T/T), and these randomly selected samples (seven individual samples in the case of the p14 ARF promoter) were used to identify polymorphisms.
PCR amplification. The PTEN 5' UTR and the promoter sequence of p14 ARF were amplified by PCR in a reaction mixture containing genomic DNA (0.1 μg), a primer set (Table 1) , and DNA polymerase (KOD Plus DNA polymerase ( [21] ; Toyobo, Osaka, Japan) for PTEN or PfuTurbo DNA polymerase ( [22] ; Stratagene, La Jolla, CA) for p14 ARF ) according to the manufacturer's instructions. Amplification was per formed in a thermal cycler (Takara PCR Thermal Cycler MP; Takara Bio, Osaka, Japan) under the fol lowing conditions: denaturation at 94°C for 15-30 s, annealing at melting temperature [Tm] -5°C for 1 min, and extension at 68-72°C for 2 min. For the promoter, intron, and exon regions of p53 and MDM2, PCR amplification was performed by using a primer set (Table 1) as described previously [6] . For the exon regions of β 2 and β 3 AR, PCR was performed by using the following primers as described previously [15, 23] : β 2 AR (forward primer: 5' GAATGAGGCTTCCAG GCGTC 3'; reverse primer: 5' GGCCCATGACCA GATCAGCA 3') and β 3 AR (forward primer: 5' CGCCCAATACCGCCAACAC 3'; reverse primer: 5' CCACCAGGAGTCCCATCACC 3').
Determination of nucleotide sequences and analysis for polymorphisms. DNA amplified by PCR (PCR products) was used for sequence reactions (for PTEN, p14 ARF , p53, and MDM2) to determine the polymor phic nucleotides. The sequence reactions were per formed using an ABI PRISM Dye Terminator Cycle Sequencing Kit (Perkin-Elmer Biosystems, Foster City, CA, USA), and nucleotide sequences were deter mined using an ABI PRISM 377 automated DNA sequencer (Perkin-Elmer Biosystems). The nucle otide sequences were compared with DNA sequences (accession nos. AF067844, AF082338.1, X54156.1, and U39736.1) in the DNA database of NCBI Gen Bank by using the basic local alignment search tool (BLAST; [24] ). For the detection of sequence alter ations, nucleotides were compared among individuals by using the sequence alignment editor program Bio Edit (http://www.mbio.ncsu.edu/BioEdit/bioedit. html), and heterozygous nucleotide sequences were analyzed in detail by changing the horizontal scale for the alignments of allelic nucleotides.
Detection of restriction fragment length polymor phisms (RFLPs) of β 2 and β 3 AR. PCR products were OHSAKA, NISHINO treated with or without a restriction enzyme (Fnu4HI; New England Biolabs, Inc., Ipswich, MA, USA (for β 2 AR) or BstOI; Promega, Madison, WI, USA (for β 3 AR)) for 2 h at 37°C in NEBuffer (New England Biolabs, Inc.) containing bovine serum albumin according to the manufacturer's protocol and sepa rated by 3% agarose gel electrophoresis. RFLPs were detected by using ethidium bromide and ultraviolet light, and we evaluated the sizes of the DNA fragments generated by treatment with or without the restriction enzyme; β 2 AR Gln/Gln at codon 27 produces 174 , 97 , 55 , and 27 bp fragments and Gln/Glu at codon 27 produces 229 , 174 , 97 , 55 , and 27 bp frag ments, and β 3 AR Trp/Trp at codon 64 produces 99 , 62 , and 30 bp fragments and Trp/Arg at codon 64 produces 161 , 99 , 62 , and 30 bp fragments. RESULTS PTEN polymorphisms and nucleotide sequence vari ations in normal Japanese individuals. We sequenced the 5' UTR upstream of the -9 position of PTEN and further determined other nucleotides in the promoter, intron, and exon regions of p53, p14 ARF , MDM2, and β 2 and β 3 AR. We detected polymorphisms in the PTEN 5' UTR (Figs. 1-3) , and in the other examined genes (Fig. 4 , and Tables 2 and 3) in normal Japanese individuals, and we observed individual differences in these sequences (Tables 2 and 3 ). These sequence vari ARF (accession no. AF082338.1), nucleotide G [57] in p53 (acces sion no. X54156.1), and nucleotide C at the 5' end of exon 2 [58] in MDM2 (accession no. U39736.1) as +1.
Vol. 46 No. 2 2012 ations comprised deleted, substituted, and inserted nucleotides. In the PTEN 5' UTR, we found a dele tion of nucleotide G ( Fig. 1 ) (nucleotide C in the opposite DNA strand to the 5' UTR sequence; Fig. 2 ) at positions -465 and -463 and a nucleotide substitu tion of C to T (Fig. 1 ) (G to A in the opposite strand to the 5' UTR; Fig. 3 ) at position -404; these polymor phisms were observed in individuals I and VIII, respectively (Table. 2). These individuals also har bored a C to C insertion at the -824 to -818 poly(C) positions of p53 ( OHSAKA, NISHINO ( Fig. A.3a) was only observed in individual III, and this individual also harbored the p53 poly(C) and MDM2 SNP309 polymorphisms ( Table 2 ). The β 3 AR codon 64 polymorphism and the p53 and MDM2 polymor phisms were simultaneously found in individuals VII and XI, in addition to I and VIII, while other individ uals (II, IV-VI, IX, X, and XII) harbored a polymor phism(s) in p53 and/or MDM2 ( Table 2 ). An A to C substitution in p14 ARF at position -3735 was not observed in any individuals ( Table 2 ). The polymor phic nucleotides in PTEN, p53, MDM2, and β 2 and β 3 AR were not identical among all normal Japanese individuals (Table 2) , but these individuals possessed the same set of associatively altered nucleotides at the MDM2 polymorphic positions -628 in exon 1 and -466 in intron 1 (the nucleotides shown as italics in Table 2 ). We also found a C to T substitution in p14 ARF at posi tion ⎯4924 (Fig. 4) by sequencing the nucleotides upstream of the p14 ARF 4.5 kb promoters in normal individuals. Similarly, the -4924 polymorphism of p14 ARF was located in associative alterations in nucle otides (types α γ in Table 3 (Table 3) . DISCUSSION Gene nucleotide alterations and their frequency distributions have been analyzed in various popula tions, including different regions, ethnic groups, and patients with diseases; however, the nucleotide varia tions in normal individuals are not still understood sufficiently. Some PTEN polymorphisms have been observed in control populations [17, 2, 1, 19] . In Jap anese or Chinese control subjects without diabetes or carcinomas, the frequency of the PTEN 5' UTR -9 polymorphism (nucleotide G) is 2.5% [2] and 6.5% [19] , respectively. This polymorphism is also detected in a Turkish population with glioblastoma multiforme (GBM) [25] , but it is not found in a Danish Caucasian population, where some intron polymorphisms have Vol. 46 No. 2 2012 been identified and association studies for diabetes have been conducted [26] . We found other PTEN 5' UTR polymorphisms at positions -465 to -463 and position -404 in normal Japanese individuals (Figs. 1-3), and we observed these polymorphisms in 1 (4.2%) and 2 (8.3%) alleles, respectively, of 24 alleles ( Table 2 ). The frequency of these PTEN polymorphisms was approximately similar to the frequency of the PTEN 5' UTR -9 polymorphism (2.5%; [2] ) in non diabetic Japanese subjects or the PTEN -1142 polymorphism in normal Japanese individuals (5.9%; [5] ). Normal Japanese individuals, including individuals I and VIII with the PTEN 5' UTR polymorphisms at positions ⎯465 to -463 and -404, harbored an insertion in the p53 promoter at the -824 to -818 poly(C) positions; substitutions in MDM2 exon 1 and intron 1 at posi tions -628, -466, and -215 (SNP309) and in β 2 and β 3 AR exon 1 at codons 27 and 64; and a substitution or deletion in p14 ARF at positions -4924, -2610, and ⎯2221 to -2218 (Tables 2 and 3 ). The frequency of the p53, MDM2, and β 2 and β 3 AR polymorphisms was not markedly different from that previously observed in normal Japanese individuals [6] and control sub jects who visited Japanese hospitals for a checkup [27, 12, 13, 15] . The -3735 polymorphism of p14 ARF was not observed in our normal Japanese individuals (Table 2) , and a Korean population had this polymor phism at a low frequency (0.03%; [11] ). The β 2 AR (Table 1) , and the digested products were separated and detected on agarose gels. 3G and 2G show PTEN nucleotides GGG and GG, respectively, at positions -465 to -463, and 7C and 8C show p53 poly(C) nucleotides CCCCCCC and CCCCCCCC, respectively, at positions -824 to -818. β 2 AR Gln/Gln and β 3 AR Trp/Trp express homozygous amino acids glutamine at codon 27 and tryptophan at codon 64, respectively. β 2 AR Gln/Glu and β 3 AR Trp/Arg show heterozygous nucle otides consisting of glutamine and glutamic acid at codon 27 and of tryptophan and arginine at codon 64, respectively. 1 The char acters in italics indicate nucleotides that are included in a set of associatively altered nucleotides. Genomic DNA was amplified by PCR with forward primers at positions -2986 to -2965 and -2702 to -2682 and reverse primers at positions -2532 to -2553 and -2157 to -2178. The nucleotide sequences were determined by direct sequenc ing of the PCR products; the sequencing reactions were performed with the primers at positions -2702 to -2682 and -2300 to ⎯2279. 4A and 2A show p14 ARF polymorphic nucleotides AAAA and AA, respectively, at positions -2218 to -2221.
OHSAKA, NISHINO codon 27 and β 3 AR codon 64 polymorphisms are observed in various races, including Asians [13] , Euro peans [23, 28] , and Caucasians [29] . The β 2 AR codon 27 polymorphism is observed at a higher frequency in Caucasian populations, but the frequency of the β 3 AR codon 64 polymorphism is similar to that observed in African-American and Hispanic Latino populations [30] . Further, the MDM2 SNP309 polymorphism is distributed differently between populations, including in patients and non diseased patients [27] , distinct regions [4] , and ethnic groups [31, 18] . Some poly morphic nucleotides, including those of p14 ARF at positions -4256, -3631 and -1477, are located in associatively altered nucleotides in a Korean popula tion [11] . Normal Japanese individuals harbor simul taneous alterations, including those in the PTEN pro moter at position -1124 and the p15 INK4b (a cyclin dependent kinase (CDK) inhibitor) promoter at posi tion -699 [5] or in the p53 promoter at the poly(C) positions and the MDM2 exon 1 and intron 2 nucle otides at positions -628 and -466 [6] . Correspond ingly, most of the normal Japanese individuals exam ined in the present study had simultaneously polymor phisms at ≥2 positions in PTEN, p53, p14 ARF , MDM2, and β 2 and β 3 AR (Tables 2 and 3 ). In the present study, healthy Japanese individuals harbored poly morphisms in the PTEN 5' UTR at positions -465 to -463 and -404 together with other polymorphisms in the promoter, intron, and exon regions of the other genes, and individual nucleotide alterations were dis tributed differently in the Japanese individuals. In addi tion, these individuals harbored some polymorphic nucleotides located in the same set of associatively altered nucleotides at positions, including positions ⎯4929, -2610, and -2221 to -2218 of p14 ARF . Our results provide helpful information for studies investi Vol. 46 No. 2 2012 gating the distribution of polymorphisms in different populations, including those of regions, races, and patients, and normal individuals.
The identification of common polymorphism pat terns in the human genome has been pursued by the research community [32] . In a Korean population, some polymorphic positions in the p14 ARF promoter, including position -3631, are included in a haplotype block (a set of single nucleotide polymorphism (SNP) alleles in a chromosomal region) [11] . Polymorphisms located in a haplotype block are useful for genotyping studies in populations with similar polymorphic alle les. The polymorphic nucleotides of MDM2 at posi tions -628 and -466 observed in our Japanese sam ples were located in the same set of associative nucle otide alterations (Table 2) , similar to those previously observed in normal Japanese individuals [6] . Likewise, the p14 ARF -4924 polymorphism found in our samples was located in such a set of associatively altered nucle otides with other p14 ARF polymorphisms (Table 3) . On the other hand, the PTEN polymorphisms at positions -465 to -463 and -404 were not involved in the set of associative alterations (Table 2) . This result appears to contrast with previous results observed by the PTEN intronic polymorphisms in non cancer patients and tumor patients [17] . Polymorphic nucleotides associa tively altered in individuals may be distributed differ ently within gene regions. The strength of linkage dis equilibrium of the MDM2 SNP309 polymorphism with other MDM2 polymorphisms differs between Ashkenazi Jewish, Caucasian, and African-American populations [18] . The polymorphisms, including the PTEN polymorphisms, found in the current study may be candidate polymorphisms for the construction of common polymorphism patterns in populations, including other ethnic groups and diseased patients.
OHSAKA, NISHINO
Further investigations with a larger number of samples are needed to determine the degree of linkage strength among polymorphisms in populations.
Gene transcript analysis with a reporter gene revealed that deletion of a region of the PTEN 5' UTR sequence alters reporter gene expression in HEK293 cells [33] . The cellular senescence inhibited gene (CSIG) binds to PTEN mRNA, and inhibition of CSIG gene expression by using small interfering RNA mod ifies the change in reporter expression following inser tion of the PTEN 5' UTR [33] . In Cos1 cells or Rat1 fibroblasts overexpressing insulin receptors, the PTEN protein level and the molecular response of Akt, a pro tein kinase, to treatment with insulin are differentially induced by the PTEN -9 polymorphism [2] . The align ment of G quadruplex nucleotides binds to cellular proteins [34] and can regulate cellular gene expression [35] [36] [37] . A search for G quadruplex motifs by using the The PCR products were treated with the indicated restriction enzyme and then separated by 3% agarose gel electrophoresis. "M" indicates a 100 bp DNA ladder. Gln/Gln (which produces 174 , 97 , 55 , and 27 bp fragments) and Trp/Trp (which produces 99 , 62 , and 30 bp fragments) express homozygous glutamine residues at codon 27 (a; β 2 AR) and tryptophan residues at codon 64 (b; β 3 AR), respectively. Gln/Glu (which pro duces 229 , 174 , 97 , 55 , and 27 bp fragments) and Trp/Arg (which produces 161 , 99 , 62 , and 30 bp fragments) indicate heterozygous nucleotides coding for glutamine and glutamic acid at codon 27 (a; β 2 AR) and tryptophan and arginine at codon 64 (b; β 3 AR), respectively. Some small fragments generated by treatment with restriction enzymes were too small to be resolved by the gel electrophoresis. Vol. 46 No. 2 2012 GRSDB2 database ( [38] ; http://bioinformatics. ramapo.edu/GQRS/) showed that the PTEN poly morphisms are located within or around a G quadru plex sequence (which is indicated by the underlined nucleotides GG in Fig. 1) . A 5' UTR polymorphism in BRCA2 at position -26 reportedly alters the RNA secondary structure of the 5' UTR and changes gene transcription activity in HeLa and MCF 7 cells [39] . The 5' UTR nucleotides around the PTEN polymor phisms at positions -465 to -463 are partially included in the alignment of the 5' GGG GAGGGGG 3' sequence motif [40] or the 5 GAG GAGGGGG 3' motif [41] located in a gene regula tory region for platelet derived growth factor A chain [40] or tissue inhibitor of metalloproteinase 2 (TIMP2) [41] ; the TIMP2 sequence motif can interact with the Sp1 and Sp3 transcription factors [41] . We searched for transcription factors that can bind to sequences around the identified PTEN polymor phisms by using the TFSEARCH program (Searching Transcription Factor Binding Sites; http://mbs.cbrc.jp/ research/db/TFSEARCH.html) with a matrix simi larity of >0.7. We also predicted the RNA secondary structure of the PTEN 5' UTR (from position -1031 to position -9; accession no. AF067844) with the CENTROIDFOLD program ( [42] ; http://www. ncrna.org/centroidfold/). TFSEARCH database analysis revealed that the PTEN polymorphisms affected the similarity of sequences of the substrates for putative transcription factors, for example, the similarity for MZF [43] at deleted nucleotide positions -465 to -463 and that for c Rel [44] at substituted nucleotide position -404 in PTEN; similar results were also obtained by other polymorphisms (in a matrix similarity of >0.65), which affected, e.g., the similarity for TATA binding protein at substituted or deleted positions -4924, -2610, and -2221 to -2218 in p14 ARF . Computational assessment with the CEN TROIDFOLD program showed that the RNA struc ture was partially altered by the PTEN polymorphisms (Figs. A.5a-A.5c) . Similarly, the PTEN 5' UTR -9 polymorphism changed the similarity for certain tran scription factors (e.g., p300; [45] ) and partially altered the structure of the 5' UTR (Figs. A.5a and A.5d) . These results indicate that the polymorphisms, including the PTEN polymorphisms, can change the binding ability of known transcription factors to the regulatory regions and that the PTEN polymorphisms can influence the interactions of complementary nucleotide sequences.
PTEN is differentially expressed in control subjects [1] and non tumor tissues [8, 9] , and PTEN gene expression has been reported to differ among patients, including those with Cowden syndrome, an autosomal dominant disorder [1] , and in individual mononuclear cells from bone marrow or peripheral blood obtained from patients with normal acute myeloid leukemia ( [46] ; data shown in accession no. GSE12417 in the NCBI Gene Expression Omnibus database). Gene expression analysis with the Cancer Genome Atlas ( [47] ; http://cancergenome.nih.gov/) has shown that PTEN levels differ among patients with cancer, including those with GBM; a number of patients with cancer harbor somatic mutations in the exonic regions of the gene; however, other patients show different gene expression levels in the absence of these muta tions. The mechanisms underlying the variable expression of PTEN among normal individuals and patients with disease remain unclear. The PTEN nucleotide alterations at polymorphic positions change transcription factor binding and affect nucle otide nucleotide interactions in silico, and PTEN mRNA interacts with cellular protein that can alter gene expression depending on the sequence of the PTEN 5' UTR [33] . Our results provide possible clues for clarifying the molecular machinery underlying the gene expression observed in individuals, including patients.
The polymorphisms of MDM2 at position SNP309, of β 2 and β 3 AR at codons 27 and 64, and of p53 at codon 72 are associated with individual predis position to diseases such as diabetes [12, 23, 48] and carcinomas [49, 27, 15, 16] in various populations, including the Japanese population. The frequency of the β 2 AR polymorphism Gln/Glu at codon 27 is increased in Caucasian females with obesity, but is decreased in obese males [29] . The β 3 AR polymor phism Trp/Arg at codon 64 is associated with cardio vascular risk factors in obese Hungarian children [28] . The p14 ARF polymorphism at position -3631 has been associated with breast cancer in a British population [50] , while the p14 ARF polymorphism at -3735 is asso ciated with diabetes in a French population with Europid ancestry [10] . The risk of chemical poisoning is associated with a polymorphism in intron 1 of p14 ARF [51] and the risk of developing tumors is associated with a polymorphism in intron 4 of PTEN [19] in a Chinese population, and these associations have been shown to be dependent on the presence of another promoter polymorphism (Del1518) in the MDM2 gene [51] and the absence of the 5' UTR -9 polymor phism in the PTEN gene [19] , respectively. The simul taneous presence of other polymorphisms has also been shown to alter the degree of disease risk by gene polymorphisms [15, 49, 39] . Normal Japanese indi viduals did not harbor the p14 ARF -3735 polymor phism, but harbored polymorphisms in the PTEN 5' UTR, in the promoter poly(C) nucleotides of p53 and other promoter nucleotides of p14 ARF , and in intron 1 and exon 1 of MDM2 and β 2 and β 3 AR (Tables 2 and 3) . Individuals II, III, VI, VII, and IX-XII harbored some simultaneous alterations in MDM2, β 2 and β 3 AR, and p53 (Table 2) , while individuals IV and V harbored either the p53 poly(C) polymorphism or the MDM2 SNP309 polymorphism, respectively ( gene expression [52] . The SNP309 polymorphism of MDM2 is adjacent to a CpG sequence. Aditionally, the cellular responses of β 2 or β 3 AR to an agonist for each receptor differ in individuals with the β 2 AR codon 27 polymorphism [53] or the β 3 AR codon 64 polymorphism [54] . Individuals I and VIII, with the PTEN polymorphisms, harbored simultaneously the p53, MDM2, and β 3 AR polymorphisms (Table 2) . A C to T substitution (C609T) in NQO1, which was commonly observed in our individuals, has been asso ciated with promoter methylation of the O 6 meth ylguanine DNA methyltransferase and p16 INK4a (another CDK inhibitor) genes [55] . In our individual samples, the nucleotide A in the p16
INK4a promoter at (Table A. 1 and some data not shown). In follow up studies and population based studies to determine the association of polymorphisms to indi vidual predispositions, polymorphisms are useful markers of an individual's constitution and as infor mation for personalized medicine. Our findings pro vide useful information for studies on the determina tion of polymorphism patterns that exhibit an individ ual's predisposition, including disease, and contribute to a better understanding of individual nucleotide vari ations. Further studies are needed to clarify individual differences in nucleotide sequences. (c)
OHSAKA, NISHINO
In the present study, we have shown that polymor phisms are observed in healthy Japanese individuals, including those at positions -465 to -463 and -404 of PTEN and position -4924 of p14 ARF , and that these individuals have a different distribution of polymor phisms in the 5' UTR, promoter, intron, and exon regions of PTEN, p53, p14 ARF , MDM2, β 2 and β 3 AR and also harbor some polymorphic nucleotides located in the same set of associative nucleotide alter ations. Most of the individuals with a nucleotide alter ation harbored other polymorphisms. Our results show that multiple nucleotides, including the PTEN nucleotides, are altered in healthy Japanese individu als and provide useful information for genotyping studies in individuals and populations.
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